• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Georgia State researcher gets $1.8 million to study gut bacteria and…

Bioengineer by Bioengineer
January 24, 2018
in Biology, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

ATLANTA–Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.8-million federal grant to study how changes in intestinal bacteria could lead to obesity and metabolic syndrome.

The United States is facing an epidemic of obesity-related disorders, including high blood pressure, high blood sugar, insulin resistance, hyperlipidemia (too many fats in the blood) and hepatic steatosis (a buildup of fat in the liver), which are collectively referred to as metabolic syndrome. Metabolic syndrome increases a person's risk of heart disease, diabetes and stroke.

Gewirtz is examining the role of gut microbiota, the diverse bacteria that normally inhabit the intestinal tract, in these diseases. Previous studies show if healthy bacteria aren't maintained in the intestine, the imbalance can result in metabolic syndrome. The grant is funded by the National Institute of Diabetes and Digestive Kidney Diseases of the National Institutes of Health.

"The overall goal of the project is to understand how alterations in bacteria in the intestine can promote low-grade inflammation and metabolic diseases, including obesity," Gewirtz said. "Additionally, we're going to be looking at how changes in diet can protect against obesity, especially how dietary fiber can alter gut bacteria in a beneficial way."

Of the project's three aims, the first is to test whether previous findings from mice studies apply to human metabolic syndrome. Gewirtz will investigate the extent to which metabolic syndrome is linked to alterations in gut microbiota that drive low-grade inflammation. The second aim is to understand how an altered microbiota actually promotes inflammation and how to protect the liver against low-grade inflammation and non-alcoholic fatty liver disease. The third aim is to examine how dietary fiber can affect the microbiota and protect against obesity. The second and third aims will be tested in mice.

"We're comparing different types of fiber," Gewirtz said. "In simple terms, you could think of fiber as being insoluble, simply just passing through and providing bulk, or fiber that can be metabolized by bacteria, which is called soluble or fermentable fiber. Our preliminary results indicate that these have very different types of effects."

Both soluble and insoluble fiber are sold in stores, and they're either found naturally in foods or added in, he said.

"Hopefully in the end we'll have a better understanding of what type should be consumed, for fibers that are naturally in foods or as supplements," Gewirtz said.

Gewirtz will collaborate with Shanti Srinivasan of Emory University for the portion of the project involving human subjects.

###

Media Contact

LaTina Emerson
[email protected]
404-413-1353
@GSU_News

Home

Share12Tweet8Share2ShareShareShare2

Related Posts

Oleanolic Acid: A Multi-Strategy Weapon Against Cancer

November 9, 2025
Embryonic Heat Manipulation: Metabolic Programming Insights

Embryonic Heat Manipulation: Metabolic Programming Insights

November 9, 2025

Weight Loss Medications Safe for Patients with High Triglycerides: No Increased Risk of Pancreatitis or Cardiac Events

November 9, 2025

Exploring Social Support’s Impact on Geriatric Cancer Patients

November 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    315 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    207 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1303 shares
    Share 520 Tweet 325

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oleanolic Acid: A Multi-Strategy Weapon Against Cancer

Embryonic Heat Manipulation: Metabolic Programming Insights

Weight Loss Medications Safe for Patients with High Triglycerides: No Increased Risk of Pancreatitis or Cardiac Events

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.